USAMRIID | Global Biodefense

Menu

UT Austin Spearheads Scalable, ELISA Antibody Test for SARS-CoV-2

USAMRIID Resumes Full Operations Following Federal Select Agent Program Reinstatement

by Global Biodefense Staff April 1, 2020, 2:12 pm
USAMRIID: America’s Key Lab for Fighting Infectious Diseases Has Become a Pentagon Backwater

by Global Biodefense Staff March 21, 2020, 5:36 pm
PharmaJet Receives $9.6 Million Dollar Award to Support Next-Generation Needle-Free Delivery Devices

by Global Biodefense Staff March 17, 2020, 4:02 pm
Why is the Defense Department Withholding Funding for USAMRIID and CCDC Chemical Biological Center?

by Global Biodefense Staff February 5, 2020, 7:19 pm
First-Ever Therapeutic Antibody Cocktail for Sudan Virus Shows Promise in Animal Studies

by Global Biodefense Staff February 4, 2020, 4:22 pm
Henry Eigelsbach, Microbiologist Known for Tularemia Research, Dies at 100

by Global Biodefense Staff December 17, 2019, 10:01 am
CDC Approves Partial Resumption of USAMRIID Select Agent Research

by Global Biodefense Staff November 23, 2019, 3:07 pm
USAMRIID Study Leads to Approval of New Smallpox Vaccine

by Global Biodefense Staff October 20, 2019, 5:01 pm
Cutting Edge Chemical and Biological Defense Science: Hot Topics at CBD S&T 2019

by Saskia Popescu, PhD October 16, 2019, 8:59 am
Biosafety Levels in Laboratories – What is the Difference?

by Frankie Catalfumo September 22, 2019, 3:22 pm
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
DoD Inspector General to Reevaluate Select Agent Facilities, Biosafety Oversight

by Stephanie Lizotte September 9, 2019, 3:23 pm
How Does USAMRIID Shut Down Impact Nation’s Bioterrorism Laboratory Response Network?

by Stephanie Lizotte August 13, 2019, 10:00 am
Lawmakers Seek Answers on USAMRIID Shutdown, BioDetection 21 Capabilities

by Global Biodefense Staff August 11, 2019, 6:18 pm
Research Halted at USAMRIID Over Biosafety Issues

by Stephanie Lizotte August 5, 2019, 7:00 am

Congratulations. You've reached the end of the internet.

Back to Top

Close